For patients to be classified as having APS, they must meet both clinical criteria (exhibiting APS clinical symptoms) and laboratory criteria (being persistently positive for any of the aPL on at least two occasions, with a minimum interval of more than 12 weeks between tests) [8,9]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.